JP3266395B2 - Crystallization method of organic chemicals - Google Patents

Crystallization method of organic chemicals

Info

Publication number
JP3266395B2
JP3266395B2 JP31911893A JP31911893A JP3266395B2 JP 3266395 B2 JP3266395 B2 JP 3266395B2 JP 31911893 A JP31911893 A JP 31911893A JP 31911893 A JP31911893 A JP 31911893A JP 3266395 B2 JP3266395 B2 JP 3266395B2
Authority
JP
Japan
Prior art keywords
crystallization
organic chemical
solvent
solution
stirring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP31911893A
Other languages
Japanese (ja)
Other versions
JPH07144102A (en
Inventor
喜久男 安藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Priority to JP31911893A priority Critical patent/JP3266395B2/en
Priority to DE1994608515 priority patent/DE69408515T2/en
Priority to EP19940118369 priority patent/EP0654291B1/en
Publication of JPH07144102A publication Critical patent/JPH07144102A/en
Application granted granted Critical
Publication of JP3266395B2 publication Critical patent/JP3266395B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03CPHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00Photosensitive materials
    • G03C1/005Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/06Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with non-macromolecular additives
    • G03C1/34Fog-inhibitors; Stabilisers; Agents inhibiting latent image regression
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03CPHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C7/00Multicolour photographic processes or agents therefor; Regeneration of such processing agents; Photosensitive materials for multicolour processes
    • G03C7/30Colour processes using colour-coupling substances; Materials therefor; Preparing or processing such materials
    • G03C7/32Colour coupling substances

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、有機薬品溶液を冷却し
て、この有機薬品溶液に溶解している有機薬品の結晶を
析出させる晶析方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a crystallization method for cooling an organic chemical solution to precipitate crystals of the organic chemical dissolved in the organic chemical solution.

【0002】[0002]

【従来の技術】工業薬品、医薬品、食品等の製造におい
ては、溶液精製では十分な精製効果を得られないことか
ら、最終製品の品質を確保するために晶析工程が設けら
れている。
2. Description of the Related Art In the production of industrial chemicals, pharmaceuticals, foods, and the like, a crystallization step is provided in order to ensure the quality of a final product because a sufficient purification effect cannot be obtained by solution purification.

【0003】この晶析工程で行われている従来の晶析方
法が、溶解度曲線のグラフとして図3に示されている。
図3の晶析操作線は模式的に示したものであるが、この
図に示すように、従来は有機薬品を良溶媒に溶かして有
機薬品溶液とした後、これを冷却し液温度を降下させ
て、準安定域及び偏平晶域を越えて塊状晶を発生させ、
そのまま塊状晶領域を通るように有機薬品溶液を冷却し
て塊状晶を析出させていた。
The conventional crystallization method used in this crystallization process is shown in FIG. 3 as a graph of a solubility curve.
The crystallization operation line in FIG. 3 is schematically shown, but as shown in this figure, conventionally, an organic chemical was dissolved in a good solvent to form an organic chemical solution, which was then cooled to lower the liquid temperature. To generate bulk crystals beyond the metastable region and the flat crystal region,
The organic chemical solution was cooled so as to pass through the bulk crystal region as it was to precipitate bulk crystals.

【0004】この塊状晶は次工程での固液分離が容易
で、晶析速度も早いため製造適性のある結晶構造である
が、反面結晶が重いため、図6に示すようなファウドラ
ー型のような小さな攪拌翼2では、析出した塊状晶を浮
遊させることができず、図6(A)に示すようにタンク
4内部の過飽和度が不均一となり、図5に示すように、
過飽和度のより高いタンク4上部では、最終的に濾過性
の悪い微細の針状晶が大量に析出し、流動性の極めて悪
いスラリーが生じる(図6(B))。
The bulk crystal has a crystal structure suitable for production because solid-liquid separation in the next step is easy and the crystallization speed is high. However, since the crystal is heavy, it is of a Faudler type as shown in FIG. With a small stirring blade 2, the precipitated bulk crystals cannot be floated, and the supersaturation inside the tank 4 becomes non-uniform as shown in FIG. 6A, and as shown in FIG.
In the upper portion of the tank 4 having a higher degree of supersaturation, a large amount of fine needle crystals having poor filtration properties are finally deposited, and a slurry having extremely poor fluidity is generated (FIG. 6B).

【0005】これを防止するためには、攪拌効率が高
く、タンク4内の過飽和度を均一にでき、塊状晶のみを
析出させることが可能な、図4に示すアンカー型のよう
な大きな攪拌翼6を備えた晶析専用の装置が必要とな
り、晶析に使用できる設備に大きな制約が課せられてい
る。
In order to prevent this, a large stirring blade such as an anchor type shown in FIG. 4 is used, which has a high stirring efficiency, can make the degree of supersaturation in the tank 4 uniform, and can precipitate only bulk crystals. 6 requires an apparatus dedicated to crystallization, which imposes great restrictions on equipment that can be used for crystallization.

【0006】[0006]

【発明が解決しようとする課題】本発明は上記事実に鑑
みてなされたものであり、攪拌効率が低くても濾過性の
良い結晶及び流動性の良いスラリーを得ることができ、
これにより汎用装置でも製造適性に優れた晶析を行うこ
とができる晶析方法を提供することを目的とする。
DISCLOSURE OF THE INVENTION The present invention has been made in view of the above-mentioned circumstances, and it is possible to obtain a crystal having good filtration properties and a slurry having good fluidity even with low stirring efficiency.
Accordingly, it is an object of the present invention to provide a crystallization method capable of performing crystallization excellent in production suitability even with a general-purpose device.

【0007】別の目的は、反応、濃縮にも使用できるフ
ァウドラー翼を有する汎用釜を用いて、高効率攪拌のア
ンカー翼を使用することなく、取り出しの容易な結晶を
得る方法を提供することである。
Another object is to provide a method for obtaining crystals which can be easily taken out using a general-purpose kettle having a Faudler blade which can also be used for reaction and concentration, without using an anchor blade with high efficiency stirring. is there.

【0008】[0008]

【課題を解決するための手段】本発明者は、上記課題を
達成すべく鋭意検討・研究した結果、偏平晶を析出させ
ることにより、汎用装置でも製造適性に優れた晶析を行
うことができることを見いだした。
Means for Solving the Problems As a result of intensive studies and studies to achieve the above object, the present inventor has found that by depositing a flat crystal, crystallization excellent in manufacturing suitability can be performed even in a general-purpose apparatus. Was found.

【0009】即ち、請求項1に記載された発明によれ
ば、有機薬品を良溶媒に溶解させ有機薬品溶液とした
後、この有機薬品溶液に該良溶媒と均一な溶液を形成す
る貧溶媒を徐々に加えて、該有機薬品溶液の過飽和度を
主として偏平晶が析出するように調整する晶析開始工
程、この晶析開始工程に引き続いて設けた、この有機薬
品溶液の飽和溶解度を低下させるように溶媒組成を変化
させつつ、この有機薬品溶液の温度を低下せしめて、主
として偏平晶の析出を継続せしめる晶析工程を有し、晶
析開始工程とこれに引き続いて設けた晶析工程を通じ
て、析出した偏平晶の流動が完全浮遊状態となるように
この有機薬品溶液を攪拌することによって有機薬品の結
晶を析出させる有機薬品の晶析方法が提供される。
That is, according to the first aspect of the present invention, an organic chemical is dissolved in a good solvent to obtain an organic chemical solution.
Later, a uniform solution with the good solvent is formed in this organic chemical solution.
That the poor solvent was added slowly, the start of crystallization step of adjusting, primarily flat crystallization degree of supersaturation of the organic chemicals solution is deposited, provided subsequent to the start of crystallization step, the saturated solubility of the organic chemical solution A crystallization step of lowering the temperature of the organic chemical solution while changing the solvent composition so as to lower the temperature, and mainly continuing the precipitation of flat crystals. Through the crystallization step, there is provided a method of crystallizing an organic chemical, in which a crystal of the organic chemical is precipitated by stirring the organic chemical solution so that the flow of the deposited flat crystal is completely suspended.

【0010】本発明は、有機薬品を製造する最終工程に
おいて、製造された有機薬品を精製するのに極めて有効
な方法である。本発明の方法が適用される有機薬品とし
ては、シアンカプラー、マゼンタカプラー、イエローカ
プラーに代表される通常写真用の発色剤、インスタント
写真用色材、かぶり防止剤等が挙げられるが、特にこれ
らに限定されず、低融点(mpが0〜50°Cが好適)
の有機化合物ならば広く適用可能である。
The present invention is a very effective method for purifying the produced organic chemical in the final step of producing the organic chemical. Examples of the organic chemicals to which the method of the present invention is applied include cyan couplers, magenta couplers, coloring agents for ordinary photographs represented by yellow couplers, coloring materials for instant photographs, antifoggants, and the like. Not limited, low melting point (mp is preferably 0 to 50 ° C)
Is widely applicable.

【0011】本発明の方法に従えば、まず、有機薬品溶
液の過飽和度を主として偏平晶が析出するように調整を
行う(晶析開始工程)。この調整はどのような方法で行
ってもよいが、例えば、有機薬品を良溶媒に溶解させ有
機薬品溶液とした後、この有機薬品溶液に貧溶媒を徐々
加えて、該有機薬品溶液の過飽和度を主として偏平晶
が析出するように調整する方法が挙げられる。
According to the method of the present invention, first, the degree of supersaturation of the organic chemical solution is adjusted so as to mainly deposit flat crystals (crystallization start step). This adjustment may be performed by any method.For example, after dissolving an organic chemical in a good solvent to form an organic chemical solution, gradually add a poor solvent to the organic chemical solution.
In addition to the above, there is a method of adjusting the degree of supersaturation of the organic chemical solution so as to mainly deposit flat crystals.

【0012】ここで「主として偏平晶が析出する」乃至
「主として偏平晶の析出を継続せしめる」とは偏平晶が
析出結晶の中で60%以上、好ましくは80%以上を占
めることをいう。
Here, "predominantly flat crystals are precipitated" or "mainly keep flat crystals deposited" means that the flat crystals occupy 60% or more, preferably 80% or more of the precipitated crystals.

【0013】また、良溶媒及び貧溶媒も当業者に周知の
用語であり、良溶媒とは溶質を溶かす能力の大きい溶媒
をいい、逆に貧溶媒とは溶質を溶かす能力が小さいか、
又はこの能力を殆ど有しない溶媒をいう。典型的には、
40°Cにおいて溶媒100gに溶質を5g以上、好ま
しくは20g以上溶解する溶媒は良溶媒であり、同じく
溶媒100gに溶質を10g以下、好ましくは1gしか
溶解しない溶媒は貧溶媒である。
A good solvent and a poor solvent are terms well known to those skilled in the art, and a good solvent means a solvent having a high ability to dissolve a solute, and a poor solvent has a small ability to dissolve a solute.
Or a solvent having almost no such ability. Typically,
A solvent that dissolves 5 g or more, preferably 20 g or more of the solute in 100 g of the solvent at 40 ° C. is a good solvent, and a solvent that dissolves the solute in 10 g or less of the solvent in 100 g of the solvent, preferably 1 g only, is a poor solvent.

【0014】多くの写真用試薬に対して酢酸エチルは良
溶媒である。また、同じくメタノール、エタノール、水
は貧溶媒である。本発明では貧溶媒を2種併用できる。
併用する貧溶媒は順次加えることもでき、予め混合して
使用することもできる。また、貧溶媒を加えた後も均一
な溶液を形成する組み合わせが好ましい。
Ethyl acetate is a good solvent for many photographic reagents. Similarly, methanol, ethanol, and water are poor solvents. In the present invention, two kinds of poor solvents can be used in combination.
The poor solvent to be used in combination can be added sequentially, or can be mixed in advance and used. A combination that forms a uniform solution even after the addition of the poor solvent is preferable.

【0015】なお、有機薬品溶液の過飽和度は3以上3
0以下となるように調整することが好ましい。ここで、
過飽和度とは、溶液濃度の絶対値の飽和濃度に対する比
をいう。
The supersaturation degree of the organic chemical solution is 3 or more and 3 or more.
It is preferable to adjust so as to be 0 or less. here,
Supersaturation refers to the ratio of the absolute value of the solution concentration to the saturation concentration.

【0016】次いで本発明の方法に従えば、この有機薬
品溶液の飽和溶解度を低下させるように溶媒組成を変化
させつつ、この有機薬品溶液の温度を低下せしめて、主
に、濾過性及び攪拌性の良好な偏平晶の析出を継続させ
る(晶析工程)。有機薬品溶液の飽和溶解度は、どのよ
うな方法で低下させてもよいが、例えば、良溶媒を溶媒
とする有機薬品溶液に貧溶媒を加えることにより過飽和
度を調整した有機薬品溶液に、水を徐々に加えて均一系
中で溶媒組成を変化させる方法が挙げられる。
Next, according to the method of the present invention, the temperature of the organic chemical solution is lowered while changing the solvent composition so as to lower the saturation solubility of the organic chemical solution, and the filterability and the stirring property are mainly reduced. The precipitation of a good flat crystal is continued (crystallization step). The saturation solubility of the organic chemical solution may be reduced by any method.For example, water is added to an organic chemical solution whose supersaturation is adjusted by adding a poor solvent to an organic chemical solution using a good solvent as a solvent. A method of changing the solvent composition in a homogeneous system by gradually adding the solvent is mentioned.

【0017】なお、析出した偏平晶は、装置内の有機薬
品溶液の過飽和度が不均一とならないように、晶析開始
工程及び晶析工程を通じて完全浮遊状態で攪拌される。
本文中でいう完全浮遊状態とは、結晶がタンク底部に1
〜2秒以上滞留しない攪拌状態をいう。
The precipitated flat crystals are stirred in a completely suspended state throughout the crystallization start step and the crystallization step so that the degree of supersaturation of the organic chemical solution in the apparatus does not become uneven.
The term “completely suspended” as used in the text means that crystals are located at the bottom of the tank.
It means a stirring state that does not stay for 2 seconds or more.

【0018】本発明の晶析方法を大スケールで実施する
に際しては、小スケールの実験装置による晶析実験の攪
拌条件を基に適切な攪拌条件を求めることができる。例
えば、百永らによる「フェノキシ酢酸化合物の晶析にお
ける粒径分析に対する攪拌効果」(化学工学論文集第1
0巻第2号、1984年発行)におけるZ因子によるス
ケールアップ方法が有効である。この方法では幾何学的
相似にスケールダウンした条件で求めた完全浮遊条件を
満たす最低攪拌条件をまず求める。次いで、スケールア
ップした条件での攪拌回転数はZ因子の値が同じになる
ようにして求めることができる。
In carrying out the crystallization method of the present invention on a large scale, appropriate stirring conditions can be determined based on the stirring conditions of a crystallization experiment using a small-scale experimental apparatus. For example, Motonaga et al., "Effect of stirring on particle size analysis in crystallization of phenoxyacetic acid compound" (Chemical Engineering Transactions No. 1).
(Vol. 0, No. 2, published in 1984) is effective. In this method, a minimum stirring condition that satisfies the complete suspension condition obtained under the condition of being scaled down geometrically similar is first determined. Next, the stirring rotation speed under the scaled-up condition can be determined so that the value of the Z factor becomes the same.

【0019】以下に本発明を実施例により説明するが、
それらは例示にすぎず、本発明はそれらに限定されるも
のではない。
Hereinafter, the present invention will be described with reference to Examples.
They are only examples, and the present invention is not limited thereto.

【0020】[0020]

【実施例】【Example】

実施例1 まず、下記構造式Iを有するシアンカプラー(1)の結
晶を取り出すために、本発明の方法をフラスコ実験にて
実施した。
Example 1 First, in order to extract a crystal of a cyan coupler (1) having the following structural formula I, the method of the present invention was carried out in a flask experiment.

【0021】[0021]

【化1】 実験装置として、フラスコ径80mmで500mlのセ
パラブルフラスコと、攪拌翼45mmの小型のファウド
ラー翼を使用した。
Embedded image As an experimental device, a separable flask having a flask diameter of 80 mm and 500 ml and a small Faudler blade having a stirring blade of 45 mm were used.

【0022】酢酸エチル43mlを入れた上記セパラブ
ルフラスコの中に、79gの上記シアンカプラー(1)
を投入した後、40°Cに加温して溶解した。次いで、
この溶液にメタノール(貧溶媒)192mlを液温度4
0°Cに保ったまま攪拌しながら徐々に加えた。さら
に、この溶液に種晶を添加し、攪拌しながら水(別の貧
溶媒)を213ml添加すると共に、20°Cまで4時
間かけて降温した。この過程で、偏平晶が析出するのが
見られ、析出した偏平晶が完全浮遊状態となるように、
攪拌速度を調節した。この時の攪拌回転数は400rp
mであった。また、40°Cから降温を開始し20°C
になるまで、過飽和度は20〜25であった。
Into the separable flask containing 43 ml of ethyl acetate, 79 g of the cyan coupler (1)
And then heated to 40 ° C. to dissolve. Then
192 ml of methanol (poor solvent) was added to this solution at a liquid temperature of 4.
While maintaining the temperature at 0 ° C., the mixture was gradually added with stirring. Further, seed crystals were added to the solution, 213 ml of water (another poor solvent) was added with stirring, and the temperature was lowered to 20 ° C. over 4 hours. In this process, flat crystals are seen to precipitate, and the precipitated flat crystals are completely suspended.
The stirring speed was adjusted. The stirring rotation speed at this time is 400 rpm
m. In addition, the temperature starts to decrease from 40 ° C
Until the supersaturation was 20-25.

【0023】20°Cに達した後、攪拌を1時間継続保
持し、5°Cまで急速に降温して、晶析得率を確保し
た。
After the temperature reached 20 ° C., the stirring was continued for 1 hour, and the temperature was rapidly lowered to 5 ° C. to secure the crystallization yield.

【0024】このようにしてできたスラリーは流動性の
良好なものであった。次いで晶析物と母液を濾別した。
The slurry thus formed had a good fluidity. Next, the crystallized product and the mother liquor were separated by filtration.

【0025】晶析物は、5μm×30μmの偏平晶であ
り、晶析得率は92%であった。上記の晶析方法を、製
造へ適用した。
The crystallized product was a flat crystal of 5 μm × 30 μm, and the crystallization yield was 92%. The above crystallization method was applied to the production.

【0026】使用した釜は4000リットルのグラスラ
イニング製であり、攪拌翼は翼径900mmのファウド
ラー型攪拌翼である。この釜及び攪拌翼を備えた晶析装
置20の概略構成が図1に示されている。
The pot used was made of 4000 liter glass lining, and the stirring blade was a Faudler type stirring blade having a blade diameter of 900 mm. FIG. 1 shows a schematic configuration of a crystallizer 20 provided with this kettle and stirring blades.

【0027】この晶析装置20は前述の釜22と、前述
の3枚のファウドラー翼(棒状翼)を備えた攪拌機24
と、上向きに傾斜した断面が略F字状のバッフル26と
を備えている。この釜22の天井22Aには略中央に開
口22Bが形成されており、この開口22Bを介して攪
拌機24のファウドラー翼が釜22内へ保持されてい
る。この攪拌機24の回転数は最大95rpm最小27
rpmの可変速ができるようになっている。天井22A
には、外周近傍に開口22Cも形成されており、この開
口22Cを介してバッフル26が釜22内へ保持されて
いる。釜22の側壁22D及び底面22Eの周囲には、
釜22内の溶液を冷却するための冷却槽28が形成され
ており、この冷却槽28には、冷却液30を冷却槽28
内に入れるための冷却液入口28Aと冷却液30を排出
するための図示しない冷却液出口が形成されている。冷
却液入口28Aと冷却液出口は図示しない管を介して熱
交換機(図示省略)と連結され、冷却液30が熱交換機
と冷却槽28の間を循環している。釜22の底面22E
の略中央部には、溶液を冷却させて得られるスラリーを
排出するための排出口22Fが形成されており、バルブ
32を介してスラリーの排出が調整される。なお、晶析
装置20は、上記の他釜22内に溶液を注入するための
溶液口と、釜22内の温度を図るための温度計を備えて
いる。また攪拌機24の攪拌翼と釜底部の一番深い中央
部との間のクリアランスは80mmであり、底部に滞留
する結晶を浮遊させ易くしている。
The crystallization apparatus 20 includes the above-described kettle 22 and the above-described stirrer 24 having three Faudler blades (rod-shaped blades).
And a baffle 26 having a generally F-shaped cross section inclined upward. An opening 22B is formed substantially at the center of the ceiling 22A of the kettle 22, and the Faudler blades of the agitator 24 are held in the kettle 22 via the opening 22B. The rotation speed of the stirrer 24 is 95 rpm at the maximum and 27 at the minimum.
A variable speed of rpm can be achieved. Ceiling 22A
The baffle 26 is also held in the shuttle 22 through the opening 22C through the opening 22C. Around the side wall 22D and the bottom surface 22E of the shuttle 22,
A cooling tank 28 for cooling the solution in the kettle 22 is formed.
A cooling liquid inlet 28A for entering the cooling liquid and a cooling liquid outlet (not shown) for discharging the cooling liquid 30 are formed. The coolant inlet 28A and the coolant outlet are connected to a heat exchanger (not shown) via a pipe (not shown), and the coolant 30 circulates between the heat exchanger and the cooling tank 28. The bottom surface 22E of the shuttle 22
A discharge port 22 </ b> F for discharging a slurry obtained by cooling the solution is formed at a substantially central portion of the, and the discharge of the slurry is adjusted via a valve 32. The crystallization apparatus 20 includes a solution port for injecting the solution into the other kettle 22 and a thermometer for measuring the temperature inside the kettle 22. The clearance between the stirring blades of the stirrer 24 and the deepest central portion of the bottom of the kettle is 80 mm, so that the crystals staying at the bottom can be easily floated.

【0028】本実施例では、冷却液としてブラインを使
用した。酢酸エチル426リットルを仕込んだ釜22の
中に、780kgの上記シアンカプラー(1)を投入し
た後、液温度を40°Cに保ったまま攪拌しながら溶解
した。次いで、この溶液にメタノール1919リットル
を液温度40°Cに保ったまま攪拌しながら徐々に加え
た。さらに、この溶液に種晶を添加し、攪拌しながら水
を2132リットル添加すると共に、20°Cまで4時
間かけて降温した。この過程で析出した偏平晶を完全浮
遊条件となる攪拌速度に調節した。この攪拌回転数は、
48rpmであった。20°Cに達した後、攪拌を1時
間継続保持し、5°Cまで急速に降温してから、遠心分
離機にて結晶と母液を濾別した。
In this embodiment, brine is used as the cooling liquid. 780 kg of the above-mentioned cyan coupler (1) was charged into the kettle 22 charged with 426 liters of ethyl acetate, and then dissolved while stirring while keeping the liquid temperature at 40 ° C. Next, 1919 liters of methanol was gradually added to the solution with stirring while maintaining the solution temperature at 40 ° C. Further, a seed crystal was added to this solution, and 2132 liters of water was added with stirring, and the temperature was lowered to 20 ° C. over 4 hours. The flat crystals precipitated in this process were adjusted to a stirring speed that was a condition of complete suspension. This stirring speed is
It was 48 rpm. After the temperature reached 20 ° C., stirring was maintained for 1 hour, and the temperature was rapidly lowered to 5 ° C., and then the crystals and the mother liquor were separated by filtration using a centrifuge.

【0029】この時のスラリーは流動性の良好なもので
あり、晶析物はフラスコと同様の偏平晶が得られた。
At this time, the slurry had good fluidity, and the crystallized product obtained was a flat crystal similar to that of the flask.

【0030】図2には、溶解度曲線及び模式的に表され
た晶析操作線が示されており、図中破線で示す溶解度曲
線は貧溶媒添加前における溶液の溶解度曲線を表し、実
線で示す溶解度曲線は貧溶媒を加えた後の溶解度曲線を
表しており、破線で示す溶解度曲線を実線で示す溶解度
曲線に降下させて、偏平晶域での晶析操作を容易にして
いる。
FIG. 2 shows a solubility curve and a schematic crystallization operation line. The solubility curve shown by a broken line in the figure represents the solubility curve of the solution before the addition of the poor solvent, and is shown by a solid line. The solubility curve represents the solubility curve after the addition of the poor solvent, and the solubility curve shown by the broken line is lowered to the solubility curve shown by the solid line to facilitate the crystallization operation in the flat crystal region.

【0031】実施例2 下記構造式IIを有するシアンカプラー(2)を実施例
1と同一のスケールアップした条件で晶析を行った場合
にも、濾過性の良い偏平晶を得ることができた。
Example 2 Even when the cyan coupler (2) having the following structural formula II was crystallized under the same scale-up conditions as in Example 1, flat crystals with good filterability could be obtained. .

【0032】[0032]

【化2】 実施例3 下記構造式IIIを有するシアンカプラー(3)を実施
例1と同一のスケールアップした条件で晶析を行った場
合にも、濾過性の良い偏平晶を得ることができた。
Embedded image Example 3 Even when the cyan coupler (3) having the following structural formula III was crystallized under the same scale-up conditions as in Example 1, a flat crystal with good filterability could be obtained.

【0033】[0033]

【化3】 実施例4 下記構造式IVを有するマゼンタカプラー中間体を実施
例1と同一のスケールアップした条件で晶析を行った場
合にも、濾過性の良い偏平晶を得ることができた。
Embedded image Example 4 Even when a magenta coupler intermediate having the following structural formula IV was crystallized under the same scale-up conditions as in Example 1, flat crystals with good filterability could be obtained.

【0034】[0034]

【化4】 Embedded image

【0035】[0035]

【発明の効果】本発明に係る有機薬品の晶析方法を用い
ることにより、攪拌効率が低くても濾過性の良い結晶及
び流動性の良いスラリーを得ることができ、これにより
汎用装置でも製造適性に優れた晶析を行うことができる
と共に、実験装置から製造設備へ適用できるスケールア
ップの方法を確立することができる。
By using the method for crystallizing organic chemicals according to the present invention, it is possible to obtain a crystal having good filtration properties and a slurry having good fluidity even if the stirring efficiency is low. In addition to performing excellent crystallization, it is possible to establish a scale-up method that can be applied to experimental equipment from manufacturing equipment.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の晶析装置の概略構成図である。FIG. 1 is a schematic configuration diagram of a crystallization apparatus of the present invention.

【図2】本発明の晶析方法における結晶形制御のモデル
を示した図である。
FIG. 2 is a diagram showing a model of crystal form control in the crystallization method of the present invention.

【図3】従来の晶析方法における結晶形制御のモデルを
示した図である。
FIG. 3 is a diagram showing a model of crystal form control in a conventional crystallization method.

【図4】従来の晶析方法における晶析の様子を示した図
であり、(A)は塊状晶が析出し始めた状態を示し、
(B)は晶析終了時の状態を示している。
FIG. 4 is a view showing a state of crystallization in a conventional crystallization method, wherein (A) shows a state in which a bulk crystal has begun to precipitate,
(B) shows the state at the end of crystallization.

【図5】従来の晶析方法においてファウドラー型攪拌翼
を使用した場合の結晶形制御のモデルを示した図であ
る。
FIG. 5 is a diagram showing a model of crystal form control when a Faudler type stirring blade is used in a conventional crystallization method.

【図6】従来の晶析方法においてファウドラー型攪拌翼
を使用した場合の晶析の様子を示した図であり、(A)
は塊状晶が析出し始めた状態を示し、(B)は晶析終了
時の状態を示している。
FIG. 6 is a view showing a state of crystallization when a Faudler-type stirring blade is used in a conventional crystallization method, and FIG.
Shows the state where the bulk crystals started to precipitate, and (B) shows the state at the end of the crystallization.

【符号の説明】[Explanation of symbols]

20 晶析装置 22 釜 24 攪拌機(ファウドラー型) 28 冷却層 Reference Signs List 20 crystallizer 22 pot 24 stirrer (Faudler type) 28 cooling layer

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 有機薬品を良溶媒に溶解させ有機薬品溶
液とした後、この有機薬品溶液に該良溶媒と均一な溶液
を形成する貧溶媒を徐々に加えて、該有機薬品溶液の過
飽和度を主として偏平晶が析出するように調整する晶析
開始工程、この晶析開始工程に引き続いて設けた、この
有機薬品溶液の飽和溶解度を低下させるように溶媒組成
を変化させつつ、この有機薬品溶液の温度を低下せしめ
て、主として偏平晶の析出を継続せしめる晶析工程を有
し、晶析開始工程とこれに引き続いて設けた晶析工程を
通じて、析出した偏平晶の流動が完全浮遊状態となるよ
うにこの有機薬品溶液を攪拌することを特徴とする有機
薬品の晶析方法。
An organic chemical is dissolved in a good solvent to dissolve the organic chemical.
Liquid and then add the good solvent and a homogeneous solution
Was slowly added a poor solvent to form a crystallization initiation step of adjusting, primarily flat crystallization degree of supersaturation of the organic chemicals solution is deposited, provided subsequent to the start of crystallization step of the organic chemical solution While changing the solvent composition so as to lower the saturation solubility, the temperature of the organic chemical solution is lowered, and a crystallization step for mainly continuing the precipitation of flat crystals is provided. A method of crystallizing an organic chemical, characterized in that the organic chemical solution is stirred so that the flow of the precipitated flat crystals is completely suspended during the crystallization step.
【請求項2】 調整後の過飽和度が3以上30以下であ
ることを特徴とする請求項記載の有機薬品の晶析方
法。
2. A crystallization method of the organic chemicals of claim 1, wherein the degree of supersaturation after the adjustment is 3 or more and 30 or less.
JP31911893A 1993-11-24 1993-11-24 Crystallization method of organic chemicals Expired - Lifetime JP3266395B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP31911893A JP3266395B2 (en) 1993-11-24 1993-11-24 Crystallization method of organic chemicals
DE1994608515 DE69408515T2 (en) 1993-11-24 1994-11-22 Process for the crystallization of organic chemicals
EP19940118369 EP0654291B1 (en) 1993-11-24 1994-11-22 Method of crystallizing organic chemicals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31911893A JP3266395B2 (en) 1993-11-24 1993-11-24 Crystallization method of organic chemicals

Publications (2)

Publication Number Publication Date
JPH07144102A JPH07144102A (en) 1995-06-06
JP3266395B2 true JP3266395B2 (en) 2002-03-18

Family

ID=18106669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP31911893A Expired - Lifetime JP3266395B2 (en) 1993-11-24 1993-11-24 Crystallization method of organic chemicals

Country Status (3)

Country Link
EP (1) EP0654291B1 (en)
JP (1) JP3266395B2 (en)
DE (1) DE69408515T2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4891194B2 (en) * 2000-05-15 2012-03-07 株式会社カネカ Method for crystallizing N- (1 (S) -ethoxycarbonyl-3-phenylpropyl) -L-alanine N-carboxyanhydride
CN1612866A (en) * 2001-11-14 2005-05-04 特瓦制药工业有限公司 Amorphous and crystalline forms of losartan potassium and process for their preparation
JP2009524654A (en) * 2006-01-26 2009-07-02 フジフィルム マニュファクチャリング ユーロプ ビー.ブイ. Precipitation method of organic compounds
KR101402734B1 (en) 2007-07-06 2014-06-02 엠. 테크닉 가부시키가이샤 Method for producing nanoparticles by forced ultra-thin film rotary processing
EP2191890B1 (en) 2007-09-21 2014-03-19 M Technique Co., Ltd. Process for producing fine particles
JP6375463B1 (en) * 2018-02-28 2018-08-15 日本曹達株式会社 Method for producing bis (fluorosulfonyl) amide alkali metal salt powder
CN118594026A (en) * 2024-08-08 2024-09-06 山西兆亿化工有限公司 Cooling crystallization equipment and crystallization method for sodium acetate preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2288667A (en) * 1938-08-15 1942-07-07 American Potash & Chem Corp Method of crystallizing substances from solution
FR1295543A (en) * 1961-04-28 1962-06-08 Aquitaine Petrole Method and apparatus for crystallization
DE2048657A1 (en) * 1970-10-03 1972-04-06 Kupka D Crystallization plant - for organic or inorganic materials in supersaturated soln and continuous operation
US4061853A (en) * 1975-12-09 1977-12-06 Ciba-Geigy Corporation Virtually solvent-free crystal form of the sodium salt of Cephacetril
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate

Also Published As

Publication number Publication date
JPH07144102A (en) 1995-06-06
DE69408515D1 (en) 1998-03-19
EP0654291A3 (en) 1996-03-20
DE69408515T2 (en) 1998-06-04
EP0654291A2 (en) 1995-05-24
EP0654291B1 (en) 1998-02-11

Similar Documents

Publication Publication Date Title
Mao et al. Enhancement of lysozyme crystallization under ultrasound field
JPH0312931B2 (en)
CN110451582B (en) Method for continuously producing ferric trichloride
JP3266395B2 (en) Crystallization method of organic chemicals
KR100596600B1 (en) Improved Process for Producing Highly Pure Aromatic Carboxylic Acids
KR101007430B1 (en) Preparation method of massive crystalline particles by controlling the solubility
JP4731980B2 (en) Method and system for crystallizing sterols
JP4259819B2 (en) Crystallization method and crystallizer
US6855176B1 (en) Emulsion crystallisation with recycle
WO2004037759A1 (en) Improved continuous crystallization method
KR101137682B1 (en) Preparation method of massive crystalline particles by controlling the solubility
CN108164413A (en) Long-chain biatomic acid continuous crystallisation equipment, system and continuous crystallisation process
JP2008036545A (en) Crystallization method
US6013808A (en) Method of purifying carbazole ester precursors of 6-chloro-α-methyl-carbazole-2-acetic acid
JP4254221B2 (en) Crystallization method of bisphenol A / phenol adduct
WO2004060525A1 (en) Method and apparatus for crystallization
AU2021105992A4 (en) A Multi-gradient Continuous Crystallization Method Applicable for the Reactive Crystallization Process
EP1077216B1 (en) Crystallization of alpha-L-aspartyl-L-phenylalanine methyl ester from supersaturated solution
Igarashi et al. Control of crystal size distribution using a mL-scale continuous crystallizer equipped with a high speed agitator
KR101813794B1 (en) Preparation method for crystallization using rotation disc crystallizer
JP2004216370A (en) Method and apparatus for crystallization
SU1710603A1 (en) Method of producing single crystals of lead iodide
SU860801A1 (en) Method and apparatus for separating substance mixtures
Lin et al. The Crystallization of Active Pharmaceutical Ingredients with Low Melting Points in the Presence of Liquid–Liquid Phase Separation. Crystals 2021, 11, 1326
CN116986984A (en) Adipic acid crystal re-melting, purifying and re-crystallizing method

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080111

Year of fee payment: 6

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080111

Year of fee payment: 6

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090111

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090111

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100111

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110111

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110111

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120111

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120111

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130111

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130111

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140111

Year of fee payment: 12

EXPY Cancellation because of completion of term